ElMedrek Mohammed Gouda, Hermez Joumana, Hutin Yvan, Abubakar Abdinasir, Muhjazi Ghada, Olatunji Emmanuel, Jamil Muhammad Shahid, Alaama Ahmed Sabry, Wilson Nevin, Abiad Firass, Yaacoub Hiam, Nakib Mostafa El
World Health Organization (WHO), Regional Office for the Eastern Mediterranean Region, Cairo, Egypt.
WHO, Country Office for Lebanon, Beirut, Lebanon.
PLoS One. 2025 Jun 13;20(6):e0321868. doi: 10.1371/journal.pone.0321868. eCollection 2025.
Lebanon faces an HIV epidemic concentrated in key populations. The national AIDS programme [NAP] hosted by WHO since 1989 achieved substantial progress towards the 95-95-95 UNAIDS targets. In 2023, we reviewed the programme to guide its planned transition back into the structure of the Ministry of Health [MOH].
In 2023, we reviewed programme documents, epidemiological information and interviewed relevant stakeholders. We compiled national data along with WHO and UNAIDS estimates to describe the evolution of programme and epidemiological indicators, along with the result chain of input, process, output, outcome and impact.
Domestic funding for the NAP increased from 73% in 2007 to 97% in 2018, before a drop in 2019 because of the financial crisis, when the NAP became dependent on international funding, including the Global Fund (commodities and services) and WHO (human resources). NAP core functions were governance, capacity building, monitoring and evaluation, anti-retro viral treatment [ART] dispensing and follow up for persons living with HIV [PLHIV] with some involvement in procurement, supply chain and laboratory testing. The NAP provided prevention, diagnosis and treatment services through Civil Society Organizations [CSOs]. In 2022, in Lebanon, 86% of PLHIV were diagnosed, among which 93% were on treatment and 95% virally suppressed. In 2022, NAP reported 232 new HIV infections, a 41% increase since 2010 and a 25% decrease in AIDS-related deaths during the same period. The estimated HIV incidence increased 4.4 times among MSM from 2008 to 2019, remained zero among commercial sex workers, and evolved from 0 to 0.11 per 1,000 to 0.9 per 1,000 in 2021 among PWIDs.
Lebanon is on track to achieve the UNAIDS 95-95-95 by 2025 targets. After transition into the MoPH, the NAP will need to [1] identify ways to sustain its sources of domestic funding, [2] build on its collaborations with CSOs to expand prevention activities in key populations, and [3] address the evolving needs of the population, including among transgenders, migrants, displaced people, and refugees, 4) maintain good quality core functions (capacity building, monitoring and evaluation, and medications).
黎巴嫩面临着集中在重点人群中的艾滋病毒疫情。自1989年以来由世界卫生组织主办的国家艾滋病规划署（NAP）在实现联合国艾滋病规划署95-95-95目标方面取得了重大进展。2023年，我们对该规划进行了审查，以指导其计划向卫生部（MOH）结构的过渡。
2023年，我们审查了规划文件、流行病学信息并采访了相关利益攸关方。我们汇编了国家数据以及世卫组织和联合国艾滋病规划署的估计数，以描述规划和流行病学指标的演变，以及投入、过程、产出、成果和影响的结果链。
国家艾滋病规划署的国内资金从2007年的73%增加到2018年的97%，但在2019年因金融危机而下降，当时国家艾滋病规划署开始依赖国际资金，包括全球基金（商品和服务）和世卫组织（人力资源）。国家艾滋病规划署的核心职能是治理、能力建设、监测和评价、抗逆转录病毒治疗（ART）分发以及对艾滋病毒感染者（PLHIV）的随访，在采购、供应链和实验室检测方面也有一定参与。国家艾滋病规划署通过民间社会组织（CSOs）提供预防、诊断和治疗服务。2022年，在黎巴嫩，86%的艾滋病毒感染者得到诊断，其中93%接受治疗，95%病毒得到抑制。2022年，国家艾滋病规划署报告了232例新的艾滋病毒感染病例，自2010年以来增加了41%，同期与艾滋病相关的死亡人数下降了25%。2008年至2019年期间，男男性行为者中估计的艾滋病毒发病率增加了4.4倍，商业性工作者中仍为零，注射吸毒者中从每1000人0至0.11例发展到2021年的每1000人0.9例。
黎巴嫩有望在2025年实现联合国艾滋病规划署95-95-95目标。过渡到卫生部后，国家艾滋病规划署将需要[1]确定维持其国内资金来源的方法，[2]在与民间社会组织合作的基础上扩大重点人群中的预防活动，[3]满足包括跨性别者、移民、流离失所者和难民在内的人群不断变化的需求，[4]维持高质量的核心职能（能力建设、监测和评价以及药物治疗）。
